PRINCIPEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Principen, and when can generic versions of Principen launch?
Principen is a drug marketed by Apothecon and Bristol Myers Squibb and is included in nine NDAs.
The generic ingredient in PRINCIPEN is ampicillin/ampicillin trihydrate; probenecid. Additional details are available on the ampicillin/ampicillin trihydrate; probenecid profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PRINCIPEN?
- What are the global sales for PRINCIPEN?
- What is Average Wholesale Price for PRINCIPEN?
Summary for PRINCIPEN
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 9 |
Raw Ingredient (Bulk) Api Vendors: | 78 |
Patent Applications: | 4,143 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PRINCIPEN at DailyMed |